Metiamide
- Level
- Commodity
- Parent
- 51171900
- Below
- 0
- Links · KBLI
- 9
Definition
UNSPSC 51171941This classification denotes a histamine-2 receptor antagonist with the molecular formula C9H16N4S2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 3K7670861M, chemically known as urea, 1-methyl-3-(2-(((5-methylimidazol-4-yl)methyl)thio)ethyl)-2-thio- but generally known as metiamide, which bears US NIH Compound Identifier 1548992. European Medicines Agency schedules Metiamide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08881MIG. The term METIAMIDE is an International Non-Proprietary Name. METIAMIDE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule metiamide under HS 29332990 and SITC 51573. As of Q4 2014, METIAMIDE remains the US FDA Preferred Term for this commodity. Metiamide bears US NLM identifiers UMLS ID C0025845 and NCI Concept Code C90862. SMILES: S(CC1NC[NH]C1C)CCNC(=S)NC.
Same parent
Under 51171900 · 73Activities that produce or sell this
KBLI · 9Inherited from family 51170000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.